We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo
Medica 2026
Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Unsuspected Bacterial Link to Bile Duct Cancer Discovered

By LabMedica International staff writers
Posted on 06 Jul 2016
Image: An adult Opisthorchis viverrini or Southeast Asian liver fluke stained with carmine (Photo courtesy of the CDC).
Image: An adult Opisthorchis viverrini or Southeast Asian liver fluke stained with carmine (Photo courtesy of the CDC).
Bacteria in the bile duct have been identified as a potential risk factor in the development of bile duct cancer, or Cholangiocarcinoma, a rare but aggressive form of cancer with symptoms that do not present themselves at the early stages.

Cholangiocarcinoma (CCA) is associated with multiple risk factors that are geographically distinct; choledocal cysts and primary sclerosing cholangitis have been implicated in the development of CCA in Western populations, while infections by the liver fluke parasite have resulted in higher incidence of CCA in Southeast Asia.

An international team of scientists working with The Agency for Science, Technology and Research (Singapore) profiled 60 primary CCA tumors and matched normals, from both 28 liver fluke (Opisthorchis viverrini) associated (Ova) and 32 non-O. viverrini associated (non-OVa) cancers, using high-throughput 16S rRNA sequencing.

Agencourt AMPure XP (Beckman Coulter, Brea, CA, USA) was used to purify the amplified products and purified products were visualized using Agilent Bioanalyzer, prepared with Agilent High Sensitivity DNA Kit (Agilent Technologies, Waldbronn, Germany). As controls for assay specificity, 16S rRNA polymerase chain reaction (PCR) was performed with extraction controls and the absence of amplification products was confirmed using Agilent Bioanalyzer.

The team discovered that bile duct tissue harbored a community of diverse bacteria species. Stenotrophomonas species, previously implicated in bile duct infections, were found to be preferentially dwelling in tumor tissue compared to normal tissue of non-fluke-infected CCA patients, highlighting their potential role in development of CCA.

In comparison to non-fluke-infected CCA tissues, fluke-infected CCA tissues were found to contain enteric bacteria whose metabolic outputs, bile acids and ammonia, have been previously linked to carcinogenesis, or the formation of cancers. Taken together, the results suggest a role for bile duct tissue microbiome in development of CCA and which may accordingly be used as a target for therapy.

Niranjan Nagarajan, PhD, the co-senior author of the study, said, “Until recently, our understanding of bacterial communities resident in our body and their association with diseases has been limited. The associations detected in this study provide a smoking gun for the role of bacteria in bile duct cancer, and we hope that this discovery will accelerate our search for a cure for cholangiocarcinoma.” The study was published in the June 2016 issue of the journal EbioMedicine.

Related Links:
The Agency for Science, Technology and Research
Beckman Coulter
Agilent Technologies

Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
βeta-Hydroxybutyrate Reagent
β-Hydroxybutyrate LiquiColor®
Automated Immunoassay Analyzer
SuperFlex™
Gold Member
Automatic Hematology Analyzer
CF9600

Channels

Clinical Chemistry

view channel
Image: Researchers combined a blood-based biomarker of Alzheimer’s disease with age, sex, and genetic risk to estimate future cognitive impairment risk in asymptomatic adults (Image Credit: Adobe Stock)

Blood Biomarker Model May Help Estimate Five- and 10-Year Cognitive Impairment Risk

Estimating future cognitive impairment risk remains challenging in cognitively healthy adults, particularly when biomarker findings are reduced to simple positive or negative results. Because mild cognitive... Read more

Molecular Diagnostics

view channel
Image: A new study links broad genomic sequencing before first-line therapy to longer survival, supporting its role in treatment decisions (Image Credit: Shutterstock)

Study Supports Broad Genomic Profiling Before First-Line Lung Cancer Treatment

Biomarker testing plays a critical role in advanced non-small cell lung cancer by identifying patients who may benefit from targeted therapies. However, testing only one or two genes can miss actionable... Read more

Immunology

view channel
Image: The findings underscore the importance of aligning allergy testing with clinical history and diagnostic guidelines to reduce inappropriate testing and its consequences (Image Credit: iStock)

Survey Finds Gap Between Food Allergy Testing Awareness and Clinical Practice

Food allergy evaluation can be challenging when laboratory results do not match clinical symptoms. Broad food allergy panels may detect sensitization without confirming an actual allergy, potentially leading... Read more

Microbiology

view channel
Image: Malaria is caused by Plasmodium parasites, primarily transmitted through the bites of infected female Anopheles mosquitoes (Image Credit: Adobe Stock)

Complete Malaria Genomes Could Improve Species Identification and Surveillance

Malaria remains a major global health challenge, with an estimated 282 million cases and 610,000 deaths worldwide in 2024. Although most research has focused on Plasmodium falciparum, Plasmodium ovale... Read more

Industry

view channel
Image Credit: iStock

C2N Makes PrecivityAD2 Alzheimer’s Blood Test Available to Clinicians

Diagnosing Alzheimer’s disease can be challenging, particularly in patients with mild cognitive impairment or early dementia. Assessing brain amyloid pathology can guide clinical decisions, but diagnostic... Read more